Sameera Irfan*

¹Envision Squint and Oculoplastics Centre, Johar Town, Lahore, Pakistan

*Corresponding Author: Sameera Irfan, Envision Squint and Oculoplastics Centre, Johar Town, Lahore, Pakistan.

Received: October 11, 2023; Published: November 27, 2023

Abstract

Acute adenoviral conjunctivitis is a common ocular surface infection that results in epidemics, globally, almost every year. Although it is self-limiting, it is highly infectious with potentially serious visual complications, thus posing considerable public health concerns. It is important to understand the disease process to make a prompt diagnosis, institute proper therapy that limits the infection and associated morbidities. Patients are injudiciously prescribed topical antibiotics and steroids that have no role in managing this condition. The education of healthcare providers and the patients on preventive strategies is necessary to limit the spread of infection.

Keywords: Human Adenovirus; Adenoviral Conjunctivitis; Immunotherapy; Povidone-Iodine; Viral Dissemination; Topical Steroids

References

1. Rowe WP., et al. “Isolation of a cytopathogenic agent from human adenoviroids undergoing spontaneous degeneration in tissue culture”. Proceedings of the Society for Experimental Biology and Medicine 3 (1953): 570-573.
2. Ishiko H., et al. “Novel human adenovirus causing nosocomial epidemic keratoconjunctivitis”. Journal of Clinical Microbiology6 (2008): 2002-2008.
3. Jones MS., et al. “New adenovirus species found in a patient presenting with gastroenteritis”. Journal of Virology11 (2007): 5978-5984.
4. Ishiko H., et al. “Novel human adenovirus causing nosocomial epidemic keratoconjunctivitis”. Journal of Clinical Microbiology6 (2008): 2002-2008.
5. Chintakuntlawar AV and Chodosh J. “Cellular and tissue architecture of conjunctival membranes in epidemic keratoconjunctivitis”. Ocular Immunology and Inflammation 5 (2010): 341-345.
6. Chigbu DI and Labib BA. “Pathogenesis and management of adenoviral keratoconjunctivitis”. Infection and Drug Resistance 11 (2018): 981-993.
7. Muller MP., et al. “Adenovirus-related epidemic keratoconjunctivitis outbreak at a hospital-affiliated ophthalmology clinic”. American Journal of Infection Control5 (2018): 581-583.
8. Centers for Disease Control and Prevention Guide to infection prevention for outpatient settings: minimum expectations for safe care (2016).
9. Radke JR and Cook JL. “Human adenovirus infections: update and consideration of mechanisms of viral persistence”. Current Opinion in Infectious Diseases 3 (2018): 251-256.
10. Zhang L., et al. “Virology and epidemiology analyses of global adenovirus-associated conjunctivitis outbreaks, 1953-2013”. Epidemiology Infection8 (2016): 1661-1672.
11. Murphy KP and Weaver C. “Janeway’s Immunobiology”. 9^th New York: Garland Science”. Basic Concepts in Immunology (2017): 1-36.
12. Flint SJ., et al. “Principles of Virology”. 3^rd Vol. 2. Washington, DC: ASM Press. Immune defenses; (2009): 86-132.
13. Chigbu DI and Labib BA. “Pathogenesis and management of adenoviral keratoconjunctivitis”. Infection and Drug Resistance 11 (2018): 981-993.
14. Yawata N., et al. “Dynamic change in natural killer cell type in the human ocular mucosa in situ as means of immune evasion by adenovirus infection”. Mucosal Immunology1 (2016): 159-170.
15. Kurna SA., et al. “Evaluation of the impact of persistent subepithelial corneal infiltrations on the visual performance and corneal optical quality after epidemic keratoconjunctivitis”. Acta Ophthalmology4 (2015): 377-382.
16. Horton JC and Miller S. “Magnetic resonance imaging in epidemic adenoviral keratoconjunctivitis”. JAMA Ophthalmology8 (2015): 960-961.
17. Jhanji V., et al. “Adenoviral keratoconjunctivitis”. Survey on Ophthalmology 5 (2015): 435-443.
18. Gouider D., et al. “Corticosteroids Versus Cyclosporine for Subepithelial Infiltrates Secondary to Epidemic Keratoconjunctivitis: A Prospective Randomized Double-Blind Study”. Cornea 6 (2021): 726-732.
19. Irfan S., et al. “To assess the efficacy and safety of Tacrolimus skin cream 0.03% in VKC”. PJO 31 (2015): 15-21.
20. “Is Post-Adenoviral Keratitis Avoidable/Preventable”. Ophthalmology Update1 (2016): 42-47.
21. Levinger E., et al. “Topical 0.03% tacrolimus for subepithelial infiltrates secondary to adenoviral keratoconjunctivitis”. Graefe's Archive for Clinical and Experimental Ophthalmology 5 (2014): 811-816.
22. Asena L., et al. “Comparison of clinical outcome with different treatment regimens in acute adenoviral keratoconjunctivitis”. Eye (Lond)5 (2017): 781-787.
23. Muftuoglu IK., et al. “Effect of 0.05% topical cyclosporine for the treatment of symptomatic subepithelial infiltrates due to adenoviral keratoconjunctivitis”. International Journal of Ophthalmology4 (2015): 634-635.
24. Monnerat N., et al. “Povidone-iodine for treatment of adenoviral conjunctivitis: an in vitro study”. Klin Monbl Augenheilkd 5 (2006): 349-352.
25. Rana Altan-Yaycioglu., et al. “Effect of diluted povidone iodine in adenoviral keratoconjunctivitis on the rate of subepithelial corneal infiltrates”. International Journal of Ophthalmology9 (2019): 1420-1425.
26. Yazar H., et al. “The effects of povidone iodine (pH 4.2) on patients with adenoviral conjunctivitis”. Journal of Pakistan Medical Association 8 (2016): 968-970.
27. Kaufman HE. “Adenovirus advances: new diagnostic and therapeutic options”. Current Opinion on Ophthalmology4 (2011): 290-293.
28. Radke JR and Cook JL. “Human adenovirus infections: update and consideration of mechanisms of viral persistence”. Current Opinion in Infectious Diseases 3 (2018): 251-256.
29. Kosulin K., et al. “Persistence and reactivation of human adenoviruses in the gastrointestinal tract”. Clinical Microbiology and Infection 4 (2016): 381 e381-381 e388.

Citation

Citation: Sameera Irfan. “Understanding Adenoviral Conjunctivitis".Acta Scientific Ophthalmology 6.12 (2023): 58-63.

Copyright

Copyright: © 2023 Sameera Irfan. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.